Pregnant or lactating women

Patients with severe cardiac disease (e.g. NYHA Functional Class III or IV, myocardial infarction within 6 months, ventricular tachyarrhythmias requiring ongoing treatment, unstable angina)

Patients with severe liver disease or severe renal disease

Simultaneous immunosuppressive treatment (e.g. steroids)

Simultaneous chemotherapy

Pretreated soft-tissue or skin metastases (e.g. cryo-, radiotherapy)

Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases

What this study is about